These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3731547)

  • 21. Platelet function in patients on maintenance hemodialysis: depressed or enhanced?
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G
    Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological changes in endometrium of hemodialyzed women of reproductive age.
    Skórzewska K; Radowicki S; Matuszkiewicz-Rowinska J; Szlendak-Sauer K
    Gynecol Endocrinol; 2007 Sep; 23(9):523-6. PubMed ID: 17943547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum calcium in dialyzed uremic patients.
    Danesh BJ; Walker CH; Mathers NP
    N Engl J Med; 1970 Jul; 283(3):155-6. PubMed ID: 5423156
    [No Abstract]   [Full Text] [Related]  

  • 25. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
    Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
    Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
    Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
    Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
    Scatizzi A; Basile C; Strippoli P; Di Maggio A; Orbello G; Lodeserto C; Triarico A; Mingrone G; Longo S; Curino E
    Chemioterapia; 1986 Oct; 5(5):327-9. PubMed ID: 3791480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Behavior of intradialysis curves of the PRA (Plasma Renin Activity) in a group of uremic patients during a periodic hemodialysis treatment].
    Farinelli A; Bagni B; Squerzanti R; Candini GC; Gilli P
    Minerva Nefrol; 1973; 20(6):376-89. PubMed ID: 4366348
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
    Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
    Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
    [No Abstract]   [Full Text] [Related]  

  • 30. [Research on some erythrocytic abnormalities in chronic uremic patients in conservative and dialytic therapy].
    Lamperi S; Sitia L; Bandiani G; Muttini P
    Minerva Nefrol; 1970; 17(6):175-80. PubMed ID: 5516050
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of peptides in the molecular etiology of uremic toxemia].
    Menyhárt J; Gróf J
    Orv Hetil; 1979 Jul; 120(30):1795-801. PubMed ID: 471491
    [No Abstract]   [Full Text] [Related]  

  • 32. Zinc, copper, magnesium and calcium in dialyzed and nondialyzed uremic patients.
    Mansouri K; Halsted JA; Gombos EA
    Arch Intern Med; 1970 Jan; 125(1):88-93. PubMed ID: 5410656
    [No Abstract]   [Full Text] [Related]  

  • 33. [Affinity of hemoglobin for oxygen in uremic patients treated with periodic hemodialysis. Comparison of the pre- and post-dialytic phases].
    Bernasconi C; Stabilini R; Graziani G; Agostoni A
    Minerva Med; 1973 Nov; 64(84):4458-62. PubMed ID: 4771470
    [No Abstract]   [Full Text] [Related]  

  • 34. Removal of uremic plasma factors using different dialysis modalities.
    Bonomini M; Bordoni E; Ciabattini F; Di Marco T; Liani M; Fantetti L; Macchiagodena G; Mancini B; Nusca C; Vecchiotti S; Sirolli V
    Hemodial Int; 2006 Jan; 10 Suppl 1():S2-4. PubMed ID: 16441863
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].
    Pigliucci GM; Suraci V; Alcini E
    Chir Patol Sper; 1974 Apr; 22(2):89-97. PubMed ID: 4434788
    [No Abstract]   [Full Text] [Related]  

  • 36. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the episodic secretion of cortisol in uremic patients on hemodialysis.
    Mishkin MS; Hsu TH; Walker G; Bledsoe T
    Johns Hopkins Med J; 1972 Aug; 131(2):160-4. PubMed ID: 5050735
    [No Abstract]   [Full Text] [Related]  

  • 38. [Entity of erythrocyte incorporation of potassium (Rb 86) studies by the in vitro incubation technic in uremic subject under continuous hemodialysis].
    Sitia L; Bandiani G
    Arch Maragliano Patol Clin; 1969; 25(3):181-4. PubMed ID: 5409171
    [No Abstract]   [Full Text] [Related]  

  • 39. [Genesis of microcytes in hemodialysis patients with chronic uremia].
    Fröber R; Halbhuber KJ; Unger J; Linss W; Stein G; Speerschneider H; Stoll W; Geyer G
    Gegenbaurs Morphol Jahrb; 1981; 127(5):654-8. PubMed ID: 7343406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Variations in prolactinemia in 26 uremic subjects treated by periodic hemodialysis].
    Deambrogio P; Vanni M; Aleo AG
    Minerva Med; 1985 Apr; 76(17-18):847-9. PubMed ID: 4000528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.